MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
about
Recent developments and best practice in brachytherapy treatment planningImage-guided brachytherapy in cervical cancer: past, present and future.Potential role of TRAns Cervical Endosonography (TRACE) in brachytherapy of cervical cancer: proof of concept.Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma.Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.MRI findings at image guided adaptive cervix cancer brachytherapy: radiation oncologist's perspectiveMRI-assisted cervix cancer brachytherapy pre-planning, based on application in paracervical anaesthesia: final report.Adaptive brachytherapy of cervical cancer, comparison of conventional point A and CT based individual treatment planning.Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.Image-based brachytherapy for cervical cancer.Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapyRecommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective studyAdaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fractionUterine perforation - 5-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology Ljubljana.High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents.Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription.Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy.A study on the variation of bladder and rectal doses with respiration in intracavitary brachytherapy for cervix cancer.The role of imaging in the management of non-metastatic cervical cancer.Brachytherapy in cancer cervix: Time to move ahead from point A?Use of 3D imaging and awareness of GEC-ESTRO recommendations for cervix cancer brachytherapy throughout Australia and New Zealand.3D reconstruction of cystoscopy videos for comprehensive bladder records.MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.Image-Guided High-Dose Rate Brachytherapy in Cervix Carcinoma Using Balloon Catheter and Belt Immobilization System.Dosimetric comparison of high dose rate brachytherapy and intensity-modulated radiation therapy for cervical carcinoma.Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy.Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer.Comparison of graphical optimization or IPSA for improving brachytheraphy plans associated with inadequate target coverage for cervical cancer.Correction of diffusion-weighted magnetic resonance imaging for brachytherapy of locally advanced cervical cancer.Adaptive error detection for HDR/PDR brachytherapy: guidance for decision making during real-time in vivo point dosimetry.Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used.Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer.
P2860
Q27027841-372A4DD7-D80D-4396-9E33-E76ED0331E6AQ30278740-0AEC6B26-83C9-47FD-863F-B460BE8FF4B4Q30376905-31C26206-C5C3-4D13-999E-614589896E2FQ33355555-BFD2AA62-DB02-4D9A-A6B4-F8316971256AQ33840842-69FD6138-FD49-4077-9350-980711056C39Q33928628-3FD26C35-7284-47C6-AA63-9C788896F6B6Q33946354-686E988F-CCCC-4657-BE91-D4BFFE770A56Q34060804-3866BA3F-D4D3-42D6-9F96-826AE6482A55Q34324918-1FCC42C9-9D51-474F-A5BE-E760E9E0306EQ34657746-BA238B7B-752E-4573-A85C-010FB9B88911Q35190699-3B38CAB8-A71A-46BF-AB41-1FA063A18F10Q35744176-71E2E9E7-CA57-47B9-83AA-95F99F368C8AQ35911703-EDA403A8-F68C-43B5-B47F-E186E68CFBCDQ36128374-32D6F5C0-A45E-425C-A703-7123C8379772Q36180787-030B1CFD-EFF0-4F33-BAD3-3B07A47BA02EQ36910392-74C18602-4B57-4AE9-AA0E-BF76E9EE774FQ36951082-F9806659-EABF-4F4F-850C-07E6B9C774ACQ37001917-000B09EC-3417-485C-84CE-061AFB673240Q37136685-F7922D9C-F2D2-4E22-AB15-099010D170C3Q37267360-48A03E12-621B-4FBB-AA95-46D3FEF6694DQ37297297-0BD7BD42-686B-4EA4-9681-7EBB218C296BQ37348135-35A2EE6C-A075-43DA-91FE-FA8AEBAB6CD7Q37432071-1794D038-50CA-433E-AB48-A32B67964C9EQ37531656-C62C5669-C5B0-4312-AF20-ABFC37140390Q38005319-383815F8-CD8E-4ACB-BC7E-58D24DE76FBFQ38258755-EBDCFF89-3604-48CA-8480-72E3D11C5762Q38427886-B7469FDB-1DC7-465D-9FFE-26B68F1A59C0Q38665535-6213B478-8B09-4E6F-9BE0-8E46494B692CQ39200622-0EBA2AE9-1151-4105-9BB5-E39823F37481Q40003362-0DE7F67B-34E4-451A-9F40-9283953CBB2FQ42107737-E293FDD4-F78A-446B-A053-B29866CE1B88Q42109646-4CF85B3A-1ECA-47E8-A331-9D0BC9D9086BQ42238577-D70278ED-C68E-4663-94C8-4920EE859DD3Q47123203-CF4D2AD0-8139-4953-BBAF-2D3555F3D634Q48847870-C26C7A97-92F3-4FE9-ABB5-1BF7F1D7187EQ51090839-313CC48D-EE27-4B0A-83ED-A35DD9D71953Q51662409-97BEF6CC-49A8-497C-A141-1491B97BB60FQ52666746-B06F00EE-3736-49DF-A125-BBFB82DE5BF5Q53642525-F292BA80-0AC5-4C94-8778-0087BABD0FC7Q54942480-D0689FAA-CB9A-413F-B45C-40407BEF6C65
P2860
MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@ast
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@en
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@nl
type
label
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@ast
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@en
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@nl
prefLabel
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@ast
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@en
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@nl
P2093
P1476
MRI-guided 3D optimization sig ...... ally advanced cervical cancer.
@en
P2093
Jacob C Lindegaard
John Gelineck
Søren Haack
Søren Kynde Nielsen
P304
P356
10.1016/J.IJROBP.2007.10.032
P407
P577
2008-01-11T00:00:00Z